Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100™ non-invasive skin cancer treatment system. The SRT-100™ will provide the local patient community with the most effective, non-surgical, and pain free therapy modality to treat non-melanoma basal and squamous cell skin cancers, which account for the vast majority of all skin cancers.
“This is a groundbreaking event for MMTC. We are honored to be able to serve the Prince of Wales Hospital of Hong Kong, a pivotal entity in the radiotherapy market in Asia. This first order is a prime example of how Sensus Healthcare of the USA integrates modern technology, safety features, and ease of use in system operation to provide the best possible solution for non-Melanoma skin cancer patients in Hong Kong.” stated George Shum, Managing Director of MMTC.
“Megatop has covered an unbelievable measure of ground in a short period of time, winning the trust and therefore the business with the Prince of Wales Hospital,” stated Rick Golin, Executive Vice President of Sales & Marketing for Sensus Healthcare. “We are very proud and pleased to have Megatop as our partner in Asia. We look forward to many more successes with them over the coming years.”
About Prince of Wales Hospital:
The Prince of Wales Hospital (Traditional Chinese: 威爾斯親王醫院) is a major public and teaching hospital located in Sha Tin, New Territories in Hong Kong. The hospital is affiliated with the Medical Faculty of the Chinese University of Hong Kong. Named after and officially opened by Charles, Prince of Wales in 1984, the Prince of Wales Hospital proudly provides its community with comprehensive quality healthcare. It is also the regional hospital responsible for the Eastern New Territories serving Shatin, Tai Po, North New Territories, Sai Kung and the outlying islands in East New Territories.
About Sensus Healthcare:
Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skincare line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.
561-922-5808 Ext 108